1. Kuehn Law is investigating potential fiduciary breaches by PepGen officers. 2. Insiders allegedly misled investors about PGN-EDO51's effectiveness and safety. 3. Concerns raised over the CONNECT2 study's safety and FDA approval viability. 4. Public statements by PepGen were reportedly misleading regarding clinical prospects. 5. The investigation may affect shareholder trust and stock performance.
The investigation hints at severe internal issues affecting trust and value. Historical examples show stock declines typically follow successful litigation against executives of biotech firms, especially when drug prospects are involved.
The legal proceedings are likely to directly impact PEPG's valuation and market perception due to potential earnings implication from halted projects and insider misconduct.
The potential negative ramifications of the investigation could immediately impact stock prices as investor sentiment reacts to litigation news.
NEW YORK, Sept. 19, 2025 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of PepGen Inc. (NASDAQ:PEPG) breached their fiduciary duties to shareholders.
According to a federal securities lawsuit, Insiders at PepGen caused the company to misrepresent or fail to disclose that (i) PGN-EDO51 was less effective and safe than insiders had led investors to believe; (ii) the CONNECT2 study was dangerous or otherwise deficient for purposes of U.S. FDA approval; (iii) as a result of all the foregoing, PepGen was likely to halt the CONNECT2 study, and PGN-EDO51's clinical, regulatory, and commercial prospects were overstated; and (iv) as a result, public statements were materially false and misleading at all relevant times.
If you currently own PEPG and purchased prior to March 7, 2024 please contact Justin Kuehn, Esq. here, by email at justin@kuehn.law or call (833) 672-0814. Kuehn Law pays all case costs and does not charge its investor clients. Shareholders should contact the firm immediately as there may be limited time to enforce your rights.
Why Your Participation Matters:
As a shareholder your voice matters, and by getting involved, you contribute to the integrity and fairness of the financial markets. Your investment. Your voice. Your future.™
For additional information, please visit Shareholder Derivative Litigation - Kuehn Law.
Attorney advertising. Prior results do not guarantee similar outcomes.
Contacts:
Kuehn Law, PLLC
Justin Kuehn, Esq.
53 Hill Street, Suite 605
Southampton, NY 11968
justin@kuehn.law
(833) 672-0814
View original content to download multimedia:https://www.prnewswire.com/news-releases/kuehn-law-encourages-investors-of-pepgen-inc-to-contact-law-firm-302561657.html
SOURCE Kuehn Law, PLLC